| Literature DB >> 30814422 |
Yuichi Fujita1, Masaaki Taniguchi1, Takashi Tsuzuki2, Tomoaki Nakai1, Yoichi Uozumi1, Hidehito Kimura1, Eiji Kohmura1.
Abstract
Secure reconstruction in transsphenoidal surgery (TSS) is important for the prevention of the major and serious complication of postoperative cerebrospinal fluid (CSF) leak. Although abdominal fat can be safely and effectively used as a reconstruction tissue, harvesting it from the abdominal wall is traumatic and invasive, resulting in cosmetic problems. In this report, we present a method of harvesting abdominal fat using a minimally invasive liposuction technique to avoid cosmetic issues. Since 2016, we have been using fat harvested from the abdominal wall by suctioning with a dedicated syringe for reconstruction after TSS in selected cases. The liquefied fat obtained by the liposuction technique was wrapped with an oxycellulose sheet and changed its form to what we termed "fatty candy". In this form, the fat maintained its configuration and could be handled almost as easily as a conventional fat graft. In our experienced series, there was no case with wound complication nor postoperative or late-onset CSF leak during a postoperative follow-up of at least 3 months. The fat harvested by this simple and minimally invasive liposuction technique can be expected to provide an autologous graft that is adequate not only for prevention of cosmetic problems but also for prevention of postoperative CSF leak.Entities:
Keywords: cerebrospinal fluid; fat graft; pituitary adenoma; rhinorrhea; transsphenoidal surgery
Year: 2019 PMID: 30814422 PMCID: PMC6527964 DOI: 10.2176/nmc.tn.2018-0270
Source DB: PubMed Journal: Neurol Med Chir (Tokyo) ISSN: 0470-8105 Impact factor: 1.742
Fig. 1.Liposuction technique and making the “fatty candy”. (A) A dedicated system for liposuction consisting of a harvesting cannula with an outer diameter of 2.1 mm, a 10-mL syringe and a snap lock (Tulip). (B) Administration of local anesthesia after disinfection and draping to expose the umbilicus and left side of the abdomen. (C) A small incision about 3 mm in length is made along the umbilical folds using a sharp-pointed scalpel. (D) Insertion of the Tulip cannula into the subcutaneous fat layer. (E) The cannula is moved back and forth applying negative pressure to aspirate liquefied fat into the syringe. (F) After the procedure, a barely visible skin incision is left along the umbilical folds (indicated with white arrow). (G) The liquefied fat harvested from the abdominal wall by the liposuction technique. (H) Appearance of the “fatty candy”, made by wrapping the liquefied fat with Surgicel Absorbable Hemostat gauze and tying both sides with a 6-0 PDS suture.
Fig. 2.Reconstruction protocol using the “fatty candy”. Intraoperative view of endoscopic endonasal transsphenoidal surgery for a recurrent pituitary adenoma in a 58-year-old woman. (A) The white arrow shows the cerebrospinal fluid leak point with a tear of the sellar diaphragm and arachnoid membrane after tumor removal. The leak was grade 2. (B and C) Packing of the “fatty candy” containing 3 mL of abdominal fat into the sella. (D and E) Suturing of the dura of the sellar floor with a 6-0 PDS suture. (F) Reconstruction of the sellar floor with nasal septal bone. (G) Repositioning of the sphenoid sinus mucosal flap to cover the sellar floor, sealed with fibrin glue. Preoperative (H) and postoperative (I; 1week later, J; 3 months later) sagittal T1-weighted magnetic resonance images for the same patient. Note the iso-intense solid tumor in (H) is replaced by “fatty candy”, which appears as a hyperintense mass in (I) and (J).
Fig. 3.“Fatty candy” used in order to mainly fill up the dead space. A non-functioning pituitary macroadenoma in a 68-year-old man. Preoperative coronal (A) and sagittal (B) T1-weighted magnetic resonance images show the massive, iso-intense and solid tumor extending to the oculomotor cistern and the sphenoid sinus. Postoperative (1 week later) coronal (C) and sagittal (D) T1-weighted magnetic resonance images show “fatty candy” as a hyperintense mass between the sella and the nasal septal mucosal flap.
Patient characteristics with pituitary adenomas treated by TSS with the liposuction technique
| Case no. | Age | Sex | Pathological diagnosis | Size macro/micro | Knosp grade | Approach | TSS times (times) | Intraoperative CSF leak grade | Amount of liposuction fat (mL) | Multilayered reconstruction | Lumbar CSF diversion | Postoperative CSF leak | Abdominal wound complication | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hematoma | Cosmetic complains | |||||||||||||
| 1 | 64 | F | GH-secreting | Micro | 1 | EETSS | Primary | 0 | 2 | + | − | No | No | No |
| 2 | 63 | M | Non-functioning | Macro | 2 | EETSS | Primary | 0 | 10 | + | − | No | No | No |
| 3 | 73 | M | Non-functioning | Macro | 3 | EETSS | Primary | 0 | 9 | + | − | No | No | No |
| 4 | 57 | F | Non-functioning | Macro | 4 | EETSS | Repeated (2) | 0 | 6 | + | − | No | No | No |
| 5 | 19 | F | PRL-secreting | Macro | 1 | EETSS | Primary | 0 | 5 | + | − | No | No | No |
| 6 | 75 | M | Non-functioning | Macro | 3 | EETSS | Primary | 0 | 6 | + | − | No | No | No |
| 7 | 45 | M | Non-functioning | Macro | 3 | EETSS | Primary | 0 | 14 | + | − | No | No | No |
| 8 | 40 | F | Non-functioning | Macro | 2 | EETSS | Primary | 0 | 9 | + | − | No | No | No |
| 9 | 15 | F | PRL-secreting | Macro | 1 | EETSS | Primary | 1 | 3 | + | − | No | No | No |
| 10 | 46 | M | Non-functioning | Macro | 1 | EETSS | Primary | 1 | 2 | − | − | No | No | No |
| 11 | 41 | F | GH, PRL-secreting | Macro | 3 | EETSS | Repeated (2) | 1 | 8 | + | − | No | No | No |
| 12 | 54 | M | Non-functioning | Macro | 3 | EETSS | Primary | 1 | 9 | + | − | No | No | No |
| 13 | 45 | M | Non-functioning | Macro | 2 | EETSS | Primary | 1 | 2 | + | − | No | No | No |
| 14 | 69 | M | Non-functioning | Macro | 3 | EETSS | Primary | 1 | 4 | + | − | No | No | No |
| 15 | 62 | M | Non-functioning | Macro | 4 | EETSS | Primary | 1 | 11 | + | − | No | No | No |
| 16 | 42 | F | ACTH-secreting | Macro | 1 | EETSS | Primary | 2 | 2 | + | − | No | No | No |
| 17 | 68 | M | Non-functioning | Macro | 4 | EETSS | Primary | 2 | 13 | + | − | No | No | No |
| 18 | 38 | F | Non-functioning | Macro | 4 | EETSS | Primary | 2 | 8 | + | − | No | No | No |
| 19 | 60 | F | Non-functioning | Macro | 2 | EETSS | Primary | 2 | 9 | + | − | No | No | No |
| 20 | 31 | F | Non-functioning | Macro | 3 | EETSS | Repeated (3) | 2 | 7 | + | − | No | No | No |
| 21 | 58 | F | Non-functioning | Macro | 2 | EETSS | Primary | 2 | 3 | + | − | No | No | No |
ACTH: adenocorticotroph hormone, CSF: cerebrospinal fluid, EETSS: endoscopic endonasal transsphenoidal surgery, F: female, GH: growth hormone, M: male, PRL: prolactin, TSS: transsphenoidal surgery.